The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Ceramide-mediated clustering is required for CD95-DISC formation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046 · cited 3×
“The death domain has been previously shown to be the critical signaling domain for CD95 apoptosis induction (Watanabe-Fukunaga et al., 1992; Itoh and Nagata, 1993; Boldin et al., 1996; Muzio et al., 1996).”
BackgroundTwo CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
Chinnaiyan, A. M., O'Rourke, K., Tewari, M., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90071-3 · Cited by 2,431
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
Green, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors
Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., & Thornberry, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32608 · Cited by 977
Structure and Origin of Ordered Lipid Domains in Biological Membranes
Brown, D. A., & London, E. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900397 · Cited by 963
Cited by
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
Ceramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3398 · Cited by 1,014
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
New insights into apoptosis signaling by Apo2L/TRAIL
Gonzalvez, F., & Ashkenazi, A. (2010) · Oncogene · doi:10.1038/onc.2010.221 · Cited by 359
Ceramide-enriched membrane domains
Bollinger, C. R., Teichgräber, V., & Gulbins, E. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.09.001 · Cited by 325
Self-citationCisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells
Lacour, S., Hammann, A., Grazide, S., Lagadic-Gossmann, D., Athias, A., Sergent, O., Laurent, G., Gambert, P., Solary, E., & Dimanche-Boitrel, M.-T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2787 · Cited by 306
Hepatic mitochondrial glutathione: transport and role in disease and toxicity
Fernandez-Checa, J. C., & Kaplowitz, N. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.001 · Cited by 288
Ceramide‐rich platforms in transmembrane signaling
Stancevic, B., & Kolesnick, R. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.026 · Cited by 288
Self-citationGajate, C., & Mollinedo, F. (2007) · Blood · doi:10.1182/blood-2006-04-016824 · Cited by 280
Mollinedo, F., & Gajate, C. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr119000439 · Cited by 279
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis
Haughey, N. J., Bandaru, V. V. R., Bae, M., & Mattson, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.003 · Cited by 273
Negri, A., Naponelli, V., Rizzi, F., & Bettuzzi, S. (2018) · Nutrients · doi:10.3390/nu10121936 · Cited by 269
Ceramide-enriched membrane domains—Structure and function
Zhang, Y., Li, X., Becker, K. A., & Gulbins, E. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.030 · Cited by 264
Self-citationCeramide function in the brain: when a slight tilt is enough
Mencarelli, C., & Martinez–Martinez, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1038-x · Cited by 263
Smith, E. L., & Schuchman, E. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-108043 · Cited by 213
Taniguchi, M., Ogiso, H., Takeuchi, T., Kitatani, K., Umehara, H., & Okazaki, T. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.82 · Cited by 57
Metadata
- Authors
- Grassmé, H., Cremesti, A., Kolesnick, R., & Gulbins, E.
- Venue
- Oncogene
- Published
- 2003-08-21
- Volume
- 22
- Issue
- 35
- Pages
- 5457-5470
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1988712957
- Cited by
- 271
- References
- 40
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.